FIELD: medicine, immunology.
SUBSTANCE: invention relates to antibodies raised against myelin-associated glycoprotein (MAG). Invention involves humanized antibody or its functional fragment that bind with MAG (myelin-associated glycoprotein) and a pharmaceutical composition containing thereof, and to using such antibodies in treatment and/or prophylaxis of neurological diseases/disturbances being insult especially. The advantage of invention involves enhancement of the neuroprotective effect in acute phase of disease.
EFFECT: valuable medicinal properties of antibodies.
6 cl, 6 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ANTIBODY IL4 USED FOR TREATMENT OF DISORDERS ASSOCIATED WITH FUNCTION OF IL4 | 1994 |
|
RU2162711C2 |
| ANTIBODY AGAINST GD2-O-ACETYLATED GANGLIOSIDE WITH PRO-APOPTOTIC ACTIVITY | 2014 |
|
RU2679715C1 |
| ANTIBODIES AGAINST CD40 AND THEIR USE | 2018 |
|
RU2796413C2 |
| ANTIBODIES TO HER3 AND APPLICATION THEREOF | 2010 |
|
RU2560583C2 |
| CHIMERIC AND HUMANISED INTEGRIN α5β1 ANTIBODIES MODULATING ANGIOGENESIS | 2003 |
|
RU2346701C2 |
| HUMANISED ANTI-CD40-ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2006 |
|
RU2407544C2 |
| ANTI-PD-1 ANTIBODY AND USE THEREOF | 2017 |
|
RU2739610C1 |
| ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 | 2018 |
|
RU2812915C2 |
| ANTI-ErbB3 ANTIBODIES | 2011 |
|
RU2568051C2 |
| ANTIBODIES RAISED AGAINST α-INTERFERON | 2002 |
|
RU2314317C2 |
